V. D. De Benedetti

Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors.

M. Hollstein, W. Bennett, G. Trivers, 1996, Cancer research.

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.

J. Jett, C. Harris, P. Pairolero, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lung carcinoma and malignant mesothelioma in patients exposed to thorotrast: Incidence, histology and p53 status

H. Wallin, H. Storm, M. Andersson, 1995, International journal of cancer.

Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression.

J. Jett, W. Travis, P. Pairolero, 1995, Carcinogenesis.

p53 mutations in lung cancer following radiation therapy for Hodgkin's disease.

M. Stovall, M. Stovall, W. Bennett, 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC.

P. Radice, M. Santoro, A. Fusco, 1991, Oncogene.

Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis.

M. Hollstein, W. Bennett, G. Trivers, 1998, Gastroenterology.

The human tropomyosin gene involved in the generation of the TRK oncogene maps to chromosome 1q31.

P. Radice, G. Sozzi, M. Pierotti, 1991, Oncogene.

p53 mutations in hepatocellular carcinoma related to oral contraceptive use.

W. Bennett, J. Welsh, V. D. De Benedetti, 1996, Carcinogenesis.

p53 is not mutated in hepatocellular carcinomas from Alaska Natives.

B. McMahon, W. Bennett, J. Welsh, 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11.

P. Radice, M. Pierotti, S. Pilotti, 1995, Genomics.

Homozygous intragenic loss of the WT1 locus in a sporadic intralobar wilms' tumor

P. Radice, M. Pierotti, S. Pilotti, 1993, International journal of cancer.

p53 tumor suppressor gene: implications for iatrogenic cancer and cancer therapy.

C. Harris, M. Greenblatt, W. Bennett, 1996, Medical and pediatric oncology. Supplement.